Landauer — Merger or Acquisition (November 2011)
15 slides from Landauer's merger presentation, Nov 15, 2011
Slide 1: Acquisition of IZI Medical Products, LLC
LANDAUER, INC. Acquisition of IZI Medical Products, LLC November 14, 2011
Slide 2: Safe Harbor Statement
This presentation may contain forward-looking statements, including statements about the outlook and prospects for Company and industry growth, as well as statements about the Company’s future financial and operating performance. Some of the information shared here constitutes forward-looking statem
Slide 3: Agenda
Agenda 61550; Introduction Landauer Strategic Plan Overview Acquisition Criteria IZI Medical Products Overview Transaction Overview LDR Dividend Policy Fiscal 2011 Guidance Q&A Session 3
Slide 4: Introduction
Introduction Landauer, Inc. (“Landauer”or the “Company”) is the global leader in radiation science and services ― Occupational Radiation Monitoring ― Medical Physics Radiation Management IZI Medical Products, LLC (“IZI”or “IZI Medical Products”) is a leading provider of high quality medical cons
Slide 5: Landauer Strategy Overview
Value Creation Deliver Upside Growth 1.Optimize Core 2.Competitive Growth 3. Strategic Expansion Strategic Priorities Landauer Strategy Overview Strategic Expansion 2006 -2010 2010 and Beyond Optimize the Core Competitive Growth New Management Restructure: Cost IT/ERP system upgrades OSL / I
Slide 6: Acquisition Criteria – Core Business
Pursue Accretive Acquisitions Market characteristics: ―Growth > GDP ―Market leader in unique or niche market ―Significant market opportunity Leverages/expands competencies ―Healthcare preference Acquisition Criteria –Core Business Demonstrated ability to identify, acquire, and seamlessly integ
Slide 7: IZI at a Glance
IZI at a Glance 1991 Founded Baltimore, MD Headquarters 30 Employees $14M Revenue YTD (nine months ended 9/30) 100% Recurring Revenue 1,000+ Annual Customers Served ($ in millions) History of Strong Revenue Growth Company Overview Provides high quality medical accessories used in Radio
Slide 8: IZI Medical Products Overview
IZI Medical Products Overview Spherz® ― Sterile, disposable passive reflective markers aid registration and instrument tracking during image guided surgery procedures Multi-Modality Markers ― Artificial reference points used on radiology image to provide clear and accurate reference point on sca
Slide 9: IZI – Market Overview
IZI –Market Overview 9 Serves the attractive Radiation Oncology, Radiology, and Image Guided Surgery end markets Image Guided Surgery global market continues to reflect strong growth opportunity ― Image Guided Surgery navigation technology can be used in a variety of medical specialties –Neurosu
Slide 10: IZI – Broad and Diverse Customer Base
IZI –Broad and Diverse Customer Base IZI’s customer base includes buyers at several stages along the supply chain including distributors, manufacturers of image guided navigation equipment, and product end users Targets community hospitals, radiation oncology clinics, mammography clinics, and im
Slide 11: Transaction Overview
Transaction Overview Acquired 100% of the outstanding equity of IZI Medical Products for approximately $93 million cash, subject to certain customary purchase price adjustments The acquisition is expected to be $0.12 to $0.16 accretive to EPS (earnings per share) in fiscal 2012 Acquisition may
Slide 12: LDR Dividend Policy
12 LDR Dividend Policy We are committed to maintaining a competitive dividend and will continue to return cash to shareholders in this manner going forward Board of Directors declared a regular quarterly cash dividend of$0.55 per share for the first quarter of fiscal 2012 – This represents an an
Slide 13: Fiscal 2011 Guidance
13 Fiscal 2011 Guidance Affirm Fiscal 2011 Guidance (provided during fiscal third quarter earnings call) – Fiscal 2011 consolidated revenue –$120 to $126 million – Fiscal 2011 net income –$24 to $26 million Full quarterly and annual results as well as an outline for fiscal 2012 guidance will be
Slide 14: Transaction Rationale
14 Transaction Rationale IZI represents a logical extension of Landauer’s radiation safety continuum ― Significant channel leverage in U.S. and international markets for expanded product offering ― Enhances complementary product / service offerings ― Accretive both financially and operationally ―
Slide 15: Questions?
LANDAUER Questions?